Clinically known as glucagon-like peptide 1 agonists , GLP-1s were originally developed to treat diabetes
Data from each treatment was collected across repeated evaluation sessions (technical replicates), and the resulting means were subjected to one-way analysis of variance (ANOVA) using SPSS (Version 23.0
Epithalon is a short-chain synthetic peptide designed to replicate the activity of the pineal peptide epithalamin
References: Babu MM, Luscombe NM, Aravind L, Gerstein M, Teichmann SA
B12 and other energy-supporting injections enhance recovery alongside exosomes and other regenerative therapies
WARNING: Risk of Thyroid C-Cell Tumors In animal studies, GLP-1 receptor agonists have been associated with thyroid C-cell tumors, including medullary thyroid carcinoma (MTC)